课题基金 / 基金详情

CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)

CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
卡罗莱纳州癌症纳米技术培训计划 (C-CNTP)
批准号:
10024629
负责人:
ALEXANDER V KABANOV
金额:
$46.71万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-07-01 至 2025-06-30

项目摘要

项目成果

ALEXANDER V KABANOV的其他基金

相似基金

相关文献

中文摘要
翻译
该提案寻求NIH T32卡罗莱纳州癌症纳米技术培训计划的竞争性延续 (C-CNTP)。该项目始于2015年,得到了美国国立卫生研究院Ruth L.Kirschstein国家研究中心的支持 服务奖。该计划的目标是为癌症的生长做出重大贡献 通过为一批精挑细选的博士后提供培训和研究经验,为纳米技术工作人员提供 伙计们。该方案自启动以来的四年里,已经招募了15名优秀研究员,其中5名 完成培训并进入终身教职轨道助理教授、行业和FDA职位,8个继续 在NIH T32支持下进行的培训和2在实验室中与其他支持来源进行的培训已进入最后阶段 他们的导师。我们已经组建了一支由来自11个部门和3个部门的20名优秀项目教师组成的团队 北卡罗来纳大学教堂山分校在物理和材料科学方面拥有专门知识的学校, 化学、药物工程、药物输送、计算建模以及基础生物医学研究 和临床科学,他们都表现出了浓厚的兴趣、能力和合作 纳米科学和癌症之间的接口。C-CNTP的目标是:1)招募一批精英 来自不同背景的博士后研究员,拥有博士、医学博士或药学博士学位,并为他们提供 出色的博士后经验,包括专注的教学培训和联合指导的研究经验 与来自互补领域的教师指导;2)为每位学员提供密集的入门培训 在线视频库,录制讲座,随后是研讨会和教学课程,以纠正 他们的背景,并加深对癌症纳米技术关键领域的知识和理解; 以及3)通过向受训者提供a)进行原创的机会,促进受训者向独立的过渡 癌症纳米技术研究项目;b)申请个人癌症纳米技术先导资助金 C)获得出版手稿、报告结果、 并成功地编写了关注癌症纳米技术问题的个人外部支持应用程序。 我们致力于开发一个世界级的博士后培训计划,利用现有的 在癌症纳米技术研究方面的优势,整合了不同领域的研究和教育资源 几个学术单位,并成为解决国家#年研究需求的重要贡献者 癌症纳米技术。
英文摘要
This proposal seeks competing continuation of the NIH T32 Carolina Cancer Nanotechnology Training Program (C-CNTP). The program started in 2015 with the support of the NIH Ruth L. Kirschstein National Research Service Award. The goal of the program is to make a major contribution to the growth of the cancer nanotechnology workforce by providing training and research experience to a highly select cohort of postdoctoral fellows. During four years since its initiation the program has recruited 15 excellent fellows of whom 5 have completed training and moved into tenure track assistant professors, industry and FDA positions, 8 continue training with the NIH T32 support and 2 are in the final stages of training with other support sources in the labs of their mentors. We have assembled a team of 20 outstanding Program faculty from 11 departments and 3 schools at the University of North Carolina Chapel Hill with specific expertise in physical and material sciences, chemistry, pharmacoengineering, drug delivery, computational modeling as well as basic biomedical research and clinical science, all of whom have demonstrated strong interests, capabilities and collaborations at the interface between nanoscience and cancer. The objectives of the C-CNTP are to: 1) recruit an elite group of talented postdoctoral fellows from diverse backgrounds with PhD, MD or PharmD and provide them with outstanding postdoctoral experience including focused didactic training and co-mentored research experience with faculty mentors from complementary fields; 2) provide each trainee with intensive introductory training with online video library of recorded lectures followed by workshops and didactic courses to remediate differences in their backgrounds and to deepen the knowledge and understanding in the key areas of cancer nanotechnology; and 3) facilitate transition of trainees to independence by providing them with opportunities to a) conduct original cancer nanotechnology research projects; b) apply for the individual cancer nanotechnology Pilot Grants within C-CNTP, and c) acquire written and oral communications skills needed to publish manuscripts, report results, and write successful individual extramural support applications focused on problems of cancer nanotechnology. We are committed to developing a world-class postdoctoral training program that capitalizes on the existing strengths in cancer nanotechnology research, consolidates diverse research and education resources across several academic units, and becomes a significant contributor to addressing the Nation's research needs in cancer nanotechnology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
  • 批准号:
    10790660
  • 项目类别:
  • 资助金额:
    $42.76万
  • 财政年份:
    2023
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10436355
  • 项目类别:
  • 资助金额:
    $60.08万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10684815
  • 项目类别:
  • 资助金额:
    $49.63万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
  • 批准号:
    10621403
  • 项目类别:
  • 资助金额:
    $11.79万
  • 财政年份:
    2021
  • 负责人:
    ALEXANDER V KABANOV
  • 依托单位:
海外基金